We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
186 hedge funds and large institutions have $1.79B invested in Acadia Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 63 increasing their positions, 59 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
18% more call options, than puts
Call options by funds: $47M | Put options by funds: $39.6M
7% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 59
4.31% less ownership
Funds ownership: 97.96% → 93.65% (-4.3%)
5% less funds holding
Funds holding: 196 → 186 (-10)
18% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 49
35% less capital invested
Capital invested by funds: $2.74B → $1.79B (-$960M)
Holders
186
Holders Change
-10
Holders Change %
-5.1%
% of All Funds
4.26%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
40
Increased
63
Reduced
59
Closed
49
Calls
$47M
Puts
$39.6M
Net Calls
+$7.31M
Net Calls Change
+$36.5M
Top Buyers
| 1 |
BlackRock
New York
|
+$55M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$35.7M |
| 3 |
State Street
Boston,
Massachusetts
|
+$29.4M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.9M |
| 5 |
O
OrbiMed
New York
|
+$16.8M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$72.7M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$63.2M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$48.7M |
| 4 |
HM
HealthCor Management
New York
|
-$31M |
| 5 |
JP Morgan Chase
New York
|
-$25.5M |
